NIPH
EW icon

NN Investment Partners Holdings’s Edwards Lifesciences EW Stock Holding History

NN Investment Partners Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$47.3M Sell
401,915
-194,439
-33% -$21.8M 0.25% 76
2021
Q4 		$77.3M Buy
596,354
+147,023
+33% +$17.1M 0.39% 52
2021
Q3 		$50.9M Buy
449,331
+171,906
+62% +$19.6M 0.28% 69
2021
Q2 		$28.7M Sell
277,425
-166,361
-37% -$15.7M 0.15% 120
2021
Q1 		$37.1M Sell
443,786
-186,150
-30% -$15.7M 0.22% 88
2020
Q4 		$57.5M Buy
629,936
+73,442
+13% +$6.09M 0.35% 57
2020
Q3 		$44.4M Sell
556,494
-13,846
-2% -$1.08M 0.29% 71
2020
Q2 		$39.4M Sell
570,340
-5,954
-1% -$423K 0.27% 72
2020
Q1 		$36.2M Sell
576,294
-38,706
-6% -$2.79M 0.3% 68
2019
Q4 		$47.8M Buy
615,000
+222,774
+57% +$17.4M 0.32% 64
2019
Q3 		$28.8M Buy
392,226
+288,288
+277% +$20.3M 0.22% 100
2019
Q2 		$6.4M Buy
103,938
+25,272
+32% +$1.53M 0.05% 283
2019
Q1 		$5.02M Sell
78,666
-11,016
-12% -$629K 0.04% 326
2018
Q4 		$4.58M Sell
89,682
-36,504
-29% -$1.85M 0.04% 296
2018
Q3 		$7.32M Sell
126,186
-21,060
-14% -$1.03M 0.05% 248
2018
Q2 		$7.14M Sell
147,246
-632,676
-81% -$29.5M 0.05% 238
2018
Q1 		$36.3M Buy
779,922
+31,401
+4% +$1.36M 0.26% 101
2017
Q4 		$28.1M Buy
748,521
+15,633
+2% +$574K 0.2% 119
2017
Q3 		$26.7M Buy
732,888
+728,484
+16,541% +$27.8M 0.17% 136
2017
Q2 		$174K Hold
4,404
– – ﹤0.01% 736
2017
Q1 		$138K Sell
4,404
-101,835
-96% -$3.19M ﹤0.01% 657
2016
Q4 		$3.32M Buy
106,239
+600
+0.6% +$19.4K 0.03% 284
2016
Q3 		$4.25M Sell
105,639
-163,608
-61% -$6.16M 0.04% 254
2016
Q2 		$8.95M Sell
269,247
-690,870
-72% -$23.6M 0.08% 179
2016
Q1 		$28.2M Buy
+960,117
New +$26.5M 0.27% 109

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NN Investment Partners Holdings's EW Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Edwards Lifesciences (EW) stake by 33% in Q1 2022, selling an estimated $21.8M and leaving 401,915 shares worth $47.3M. The position accounts for 0.25% of the portfolio, ranked #76.

NN Investment Partners Holdings first reported a position in EW in Q1 2016 and has held it in 25 quarters since. The position peaked at $77.3M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • NN Investment Partners Holdings held 401,915 shares of Edwards Lifesciences worth $47.3M as of Q1 2022.
  • NN Investment Partners Holdings sold 194,439 Edwards Lifesciences shares in Q1 2022, an estimated $21.8M.
  • Edwards Lifesciences made up 0.25% of NN Investment Partners Holdings's portfolio in Q1 2022, its #76 holding.
  • NN Investment Partners Holdings first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Edwards Lifesciences position peaked at $77.3M in Q4 2021.
  • 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.